# Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)

> **NCT01422616** · PHASE3 · COMPLETED · sponsor: **The George Institute** · enrollment: 4587 (actual)

## Conditions studied

- Ischemic Stroke
- High Blood Pressure

## Interventions

- **DRUG:** Low-dose rtPA
- **DRUG:** Standard-dose rtPA
- **OTHER:** Intensive blood pressure (BP) lowering
- **OTHER:** BP management policies

## Key facts

- **NCT ID:** NCT01422616
- **Lead sponsor:** The George Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 4587 (ACTUAL)
- **Last updated:** 2021-10-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01422616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01422616, "Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01422616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*